Clinical Trials
7
Active:4
Completed:1
Trial Phases
1 Phases
Phase 1:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (100.0%)Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy
Phase 1
Terminated
- Conditions
- Rotator Cuff Tear
- Interventions
- Drug: Suspension of human autologous MSC 3P
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Bioinova, s.r.o.
- Target Recruit Count
- 9
- Registration Number
- NCT03838666
Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis
Phase 1
Completed
- Conditions
- Motor Neuron Disease, Amyotrophic Lateral Sclerosis
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- Bioinova, s.r.o.
- Target Recruit Count
- 26
- Registration Number
- NCT03828123
Utilization of Autologous Mesenchymal Cells in Posterolateral Spinal Fusion in Degenerative Spine Disease
Phase 1
Terminated
- Conditions
- Degenerative Disc Disease
- Interventions
- Drug: Suspension of human autologous MSC 3P in 1.5 ml
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Bioinova, s.r.o.
- Target Recruit Count
- 10
- Registration Number
- NCT03827096
News
No news found